Lee Gary K.

Track

Insider profile

Performance

Overall performance
2.8
Performance over holding periods
2.8
30 days 90 days 120 days
Average return 5% 8.2% 15.1%
Success rate 74% 68% 82%
Transactions
7 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Lee Gary K.'s trades of Lyell Immunopharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
436.20
Quantity 81,405 -13.9%
Value US$4,515,257
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-25 2026-08-21
S Sale
83,839 -23.4%
492.84
US$507,236 		83,839 -23.4% 492.84 US$507,236
2026-08-11 2026-08-10
S Sale
99,609 -1.4%
419.41
US$1,565,252 		99,609 -1.4% 419.41 US$1,565,252
2026-06-15 2026-05-11
PlS Planned sale
81,405 -13.9%
436.20
US$4,515,257 		81,405 -13.9% 436.20 US$4,515,257
2026-02-12 2026-02-11
S Sale
1,671 -9.0%
23.39
US$39,085 		1,671 -9.0% 23.39 US$39,085
2026-02-11 2026-02-10
S Sale
147 -0.8%
23.12
US$3,399 		147 -0.8% 23.12 US$3,399
2025-11-12 2025-11-10
S Sale
138 -0.9%
16.16
US$2,230 		138 -0.9% 16.16 US$2,230
2025-08-22 2025-08-21
S Sale
1,453 -8.6%
10.54
US$15,320 		1,453 -8.6% 10.54 US$15,320
2025-08-13 2025-08-12
S Sale
136 -1.5%
10.34
US$1,406 		136 -1.5% 10.34 US$1,406
2025-08-13 2025-08-11
PlS Planned sale
131 -1.4%
10.53
US$1,379 		131 -1.4% 10.53 US$1,379